In a study assessing an Angelman syndrome model using Ube3a-expressing lentivectors in haemopoietic stem cells to deliver functional UBE3A, the authors suggested that their approach is not dependent on a critical time window [48]. This evidence concerns the gene UBE3A and Angelman syndrome.